Liver function may affect new diabetes Drug's safety
NCT ID NCT06961643
First seen Mar 09, 2026 · Last updated May 19, 2026 · Updated 9 times
Summary
This study looked at how the body handles HRS-7535, a potential diabetes drug, in people with mild or moderate liver impairment compared to those with normal liver function. 24 adults participated to measure drug levels and safety. The goal is to understand if liver problems change how the drug works, helping guide future dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Henan Provincial Infectious Disease Hospital
Zhengzhou, Henan, 450015, China
Conditions
Explore the condition pages connected to this study.